However, CRP has been studied and suggested as a biomarker for numerous acute and chronic diseases, and it remains to be studied whether its best value in treating patients with psychotic disorders would actually be found in assessing the risk of comorbidities (e.g., in cardiovascular risk assessment) (124). Here, CRP is linked to psychotic disorder.